Androgen Deprivation and Localized Radiotherapy to Metastases in Patients With Oligometastatic Hormone - Sensitive Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2018
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin (Primary) ; Leuprorelin (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.
- 02 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.